Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter J. Rosen
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Alterations in Error-Related Brain Activity and Post-Error Behavior Over Time
Brain and Cognition
Developmental
Arts
Cognitive Psychology
Neuropsychology
Educational Psychology
Humanities
Cognitive Neuroscience
Physiological Psychology
Experimental
Related publications
Binimetinib Plus Gemcitabine and Cisplatin Phase I/Ii Trial in Patients With Advanced Biliary Cancers
Clinical Cancer Research
Cancer Research
Oncology
A Phase II Trial of Fixed-Dose Rate Gemcitabine Plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients
Oncology
Medicine
Cancer Research
Oncology
Phase I Dose-Escalation Study of Copanlisib in Combination With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
British Journal of Cancer
Cancer Research
Oncology
Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study
British Journal of Cancer
Cancer Research
Oncology
Meta-Analysis of Randomized Phase II and Phase III Trials of Gemcitabine With/Without S-1 in Asian Patients With Advanced Pancreatic Cancer.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Galunisertib Plus Gemcitabine vs. Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer
British Journal of Cancer
Cancer Research
Oncology
A Multicentre Randomised Phase II Trial of Gemcitabine Alone vs Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: GEMSAP Study
British Journal of Cancer
Cancer Research
Oncology
Gemcitabine Plus Carboplatin in Patients With Advanced Hepatocellular Carcinoma: Results of a Phase II Study
ISRN Oncology
Performance Status Dynamics During Treatment With Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Metastatic Pancreatic Cancer
Cancer Management and Research
Oncology
